Articles
Bioneer Targets H2 2022 Euro Launch Of CosmeRNA: Update (3/9/22) Bioneer/siRNAgen has apparently been evaluating its CosmeRNA product for cosmetic regulatory approval in Germany over the past several months. Various news outlets in the Korean press reported on March 8, 2022 that CosmeRNA has received an “excellent” safety evaluation by Dermatest, an accredited agency based…
Read More
HMI-115 Phase 2 Trial Begins In China: Update (11/7/23) Just under 2 years since this original article was published, Hope Medicine has officially launched a phase 2 clinical trial for HMI-115 in China. The study is listed on ClinicalTrials.gov and the actualy start date of the trial was in September 2023. Details are as follows: …
Read More
Follicle Thought is pleased to announce a new company developing a cellular reprogramming technology for the purpose of hair regeneration, a potential true cure for hair loss. Enter dNovo After operating in stealth mode over the last several years, it appears that dNovo is ready to make some waves in the cellular reprogramming space. dNovo…
Read More
An interesting new hair growth patent has surfaced online from the Nichinichi Pharmaceutical Company of Japan. NF-1011 – Enterococcus faecalis Nichinichi Pharmaceutical Co. specializes in the research and development of lactic acid bacteria strains for therapeutic uses. The current flagship product of the company is called FK-23, a proprietary formulation of the Enterococcus faecalis bacteria.…
Read More
In this article we will hear about recent advances made by Epibiotech in their efforts to create an effective cell therapy for hair growth. Korean Biotech Specializing In Hair Follicle Research Below is a quick video displaying the company atmosphere at Epibiotech. This video is also shared on the homepage of Epibiotech’s website. Note, the…
Read MoreThis article contains a complete list and description of every known biotech and med-tech company working on a clinical therapy for hair loss prevention/hair growth from all phases spanning research to late-stage clinical trials in 2024/2025. Over the past several years, the amount of new hair growth related technologies in development have multiplied like never…
Read More
Follicle Thought is very pleased to share this exclusive interview with the CEO of Stemson Therapeutics, Geoff Hamilton. Follicle Thought: Hi Geoff, thank you for doing this interview with Follicle Thought. To start, could you please tell us about how you met Dr. Alexey Terskikh and went on to become Stemson’s CEO? Geoff Hamilton: Well, thank…
Read More
Kintor Pharmaceutical of China brings us some timely good news today regarding its lead candidate drug KX-826 for the treatment of androgenetic alopecia. Phase 3 Will Be Soon A well respected company in the hair growth industry, Kintor Pharmaceutical, continues to outpace the competition. In a press release issued today, the company announced that KX-826…
Read More
This article covers a few companies not previously discussed online and recent happenings in hair growth related news. AddPharma of Korea Where else would new hair growth medicine be coming out of but Korea? In the case of AddPharma, it’s a mixture of “old and new”, but we’ll take it. AddPharma is a pharmaceutical company…
Read More
In this article we will cover the most prominent therapeutic candidates in the alopecia areata treatment industry in 2025. Alopecia Areata Pharmaceutical & Biotech Therapies In Development AnaptysBio – Rosnilimab or ANB030 is a Anti-PD-1 agonist. It is currently being evaluated in a 45 patient phase 2 clinical trial in moderate to severe alopecia areata.…
Read More